Idiopathic acute myocarditis during treatment for controlled human malaria infection: A case report

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Van Meer, Maurits P A ^a   Bastiaens, Guido J H ^a   Boulaksil, Mohamed ^a   De Mast, Quirijn ^a   Gunasekera, Anusha ^b   Hoffman, Stephen L ^b   Pop, Gheorghe ^a   Van Der Ven, André J A M ^a   Sauerwein, Robert W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SANARIA INC   (United States)

Author keywords

CHMI; Malaria; MRI; Myocarditis; Troponin T

Indexed keywords

ANTIMALARIALS; ATOVAQUONE; DRUG COMBINATIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MALARIA, FALCIPARUM; MALE; MYOCARDITIS; PLASMODIUM FALCIPARUM; PROGUANIL; TROPONIN T; YOUNG ADULT;

EID: 84893173741     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-38     Document Type: Article

References (40)

1. Malaria transmitted to humans by mosquitoes infected from cultured Plasmodium falciparum. Chulay JD, Schneider I, Cosgriff TM, Hoffman SL, Ballou WR, Quakyi IA, Carter R, Trosper JH, Hockmeyer WT, Am J Trop Med Hyg 1986 35 66 68 3511753 (Pubitemid 16140838)
2. Experimental human challenge infections can accelerate clinical malaria vaccine development. Sauerwein RW, Roestenberg M, Moorthy VS, Nat Rev Immunol 2011 11 57 64 10.1038/nri2902 21179119
3. Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes. Verhage DF, Telgt DS, Bousema JT, Hermsen CC, van Gemert GJ, van der Meer JW, Sauerwein RW, Neth J Med 2005 63 52 58 15768480 (Pubitemid 40347734)
4. Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update. Epstein JE, Rao S, Williams F, Freilich D, Luke T, Sedegah M, de la Vega P, Sacci J, Richie TL, Hoffman SL, J Infect Dis 2007 196 145 154 10.1086/518510 17538895 (Pubitemid 46982749)
5. Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. Church LW, Le TP, Bryan JP, Gordon DM, Edelman R, Fries L, Davis JR, Herrington DA, Clyde DF, Shmuklarsky MJ, Schneider I, McGovern TW, Chulay JD, Ballou WR, Hoffman SL, J Infect Dis 1997 175 915 920 10.1086/513990 9086149 (Pubitemid 27142967)
6. Protection against a malaria challenge by sporozoite inoculation. Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, van Gemert GJ, van de Vegte-Bolmer M, van Schaijk B, Teelen K, Arens T, Spaarman L, de Mast Q, Roeffen W, Snounou G, Rénia L, van der Ven A, Hermsen CC, Sauerwein R, N Engl J Med 2009 361 468 477 10.1056/NEJMoa0805832 19641203
7. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Roestenberg M, Teirlinck AC, McCall MB, Teelen K, Makamdop KN, Wiersma J, Arens T, Beckers P, van Gemert G, van de Vegte-Bolmer M, van der Ven AJ, Luty AJ, Hermsen CC, Sauerwein RW, Lancet 2011 377 1770 1776 10.1016/S0140-6736(11)60360-7 21514658
8. Controlled human malaria infections by intradermal injection of cryopreserved Plasmodium falciparum sporozoites. Roestenberg M, Bijker EM, Sim BK, Billingsley PF, James ER, Bastiaens GJ, Teirlinck AC, Scholzen A, Teelen K, Arens T, van der Ven AJ, Gunasekera A, Chakravarty S, Velmurugan S, Hermsen CC, Sauerwein RW, Hoffman SL, Am J Trop Med Hyg 2013 88 5 13 10.4269/ajtmh.2012.12- 0613 23149582
9. Optimising controlled human malaria infection studies using cryopreserved P. falciparum parasites administered by needle and syringe. Sheehy SH, Spencer AJ, Douglas AD, Sim BK, Longley RJ, Edwards NJ, Poulton ID, Kimani D, Williams AR, Anagnostou NA, Roberts R, Kerridge S, Voysey M, James ER, Billingsley PF, Gunasekera A, Lawrie AM, Hoffman SL, Hill AV, PLoS One 2013 8 65960 10.1371/journal.pone.0065960 23823332
10. Hematologic changes in acute, imported Plasmodium falciparum malaria. Richards MW, Behrens RH, Doherty JF, Am J Trop Med Hyg 1998 59 859 9886188 (Pubitemid 29028910)
11. Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. Sarda L, Colin P, Boccara F, Daou D, Lebtahi R, Faraggi M, Nguyen C, Cohen A, Slama MS, Steg PG, Le Guludec D, J Am Coll Cardiol 2001 37 786 792 10.1016/S0735-1097(00)01201-8 11693753 (Pubitemid 32202446)
12. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P, International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis, J Am Coll Cardiol 2009 53 1475 1487 10.1016/j.jacc.2009.02.007 19389557
13. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ, Eur Heart J 2005 26 1461 1474 10.1093/eurheartj/ehi258 15831557 (Pubitemid 41373486)
14. Angiotensin II receptor antagonism reverts the selective cardiac BNP upregulation and secretion observed in myocarditis. Ogawa T, Veinot JP, Kuroski de Bold ML, Georgalis T, de Bold AJ, Am J Physiol Heart Circ Physiol 2008 294 2596 H2603 10.1152/ajpheart.00215.2008 18408131
15. NTproBNP: an important biomarker in cardiac diseases. Panagopoulou V, Deftereos S, Kossyvakis C, Raisakis K, Giannopoulos G, Bouras G, Pyrgakis V, Cleman MW, Curr Top Med Chem 2013 13 82 94 10.2174/1568026611313020002 23470072
16. Myocarditis associated with Plasmodium falciparum malaria: a case report and a review of the literature. Mohsen AH, Green ST, West JN, McKendrick MW, J Travel Med 2001 8 219 220 11712506 (Pubitemid 33143867)
17. Fatal malaria in a german couple returning from burkina faso. Wichmann O, Loscher T, Jelinek T, Infection 2003 31 260 262 14562954 (Pubitemid 36960565)
18. Fatal myocarditis in course of Plasmodium falciparum infection: case report and review of cardiac complications in malaria. Costenaro P, Benedetti P, Facchin C, Mengoli C, Pellizzer G, Case Rep Med 2011 2011 202083 21541220
19. Fatal complications of tropical malaria in non-immune patients. A retrospective clinico-pathologic analysis of 25 cases. Horstmann RD, Ehrich JH, Beck J, Dietrich M, Dtsch Med Wochenschr 1985 110 1651 1656 10.1055/s-2008- 1069063 3899570 (Pubitemid 16192648)
20. Severe malaria-analysis of prognostic symptoms and signs in 169 patients treated in Gdynia in 1991-2005. Goljan J, Nahorski WL, Wroczynska A, Felczak-Korzybska I, Pietkiewicz H, Int Marit Health 2006 57 149 162 17312703
21. Varied presentation of complicated falciparum malaria in a family. Sanklecha M, Mehta N, Bagban H, Indian Pediatr 2012 49 413 414 22700669
22. Myocarditis in malignant tertian malaria. Greenfield I, N Y State J Med 1895 1947 47
23. A case of myocarditis associated with Plasmodium vivax malaria. Kim SA, Kim ES, Rhee MY, Choi SI, Huh HJ, Chae SL, J Travel Med 2009 16 138 140 10.1111/j.1708-8305.2008.00292.x 19335817
24. Myocardial damage in falciparum malaria detectable by cardiac troponin T is rare. Günther A, Grobusch MP, Slevogt H, Abel W, Burchard GD, Trop Med Int Health 2003 8 30 32 10.1046/j.1365-3156.2003.00978.x 12535247 (Pubitemid 36151575)
25. High levels of circulating cardiac proteins indicate cardiac impairment in African children with severe Plasmodium falciparum malaria. Ehrhardt S, Mockenhaupt FP, Anemana SD, Otchwemah RN, Wichmann D, Cramer JP, Bienzle U, Burchard GD, Brattig NW, Microbes Infect 2005 7 1204 1210 10.1016/j.micinf.2005. 04.007 16002312 (Pubitemid 41476433)
26. Cardiac complication after experimental human malaria infection: a case report. Nieman AE, de Mast Q, Roestenberg M, Wiersma J, Pop G, Stalenhoef A, Druilhe P, Sauerwein R, van der Ven A, Malar J 2009 8 277 10.1186/1475-2875-8- 277 19958549
27. Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate. Gupta RK, Van Vugt M, Paiphun L, Slight T, Looareesuwan S, White NJ, Nosten F, Am J Trop Med Hyg 2005 73 267 268 16103586 (Pubitemid 41278695)
28. Myocarditis. Cooper LT Jr, N Engl J Med 2009 360 1526 1538 10.1056/NEJMra0800028 19357408
29. Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Calabrese F, Thiene G, Cardiovasc Res 2003 60 11 25 10.1016/S0008-6363(03)00475-9 14522403 (Pubitemid 38373472)
30. Etiology and pathogenesis of myocarditis-UpToDate. Cooper LT, 2013 http://www.uptodate.com. Ref Type: Report
31. Enteroviral myocarditis and dilated cardiomyopathy: a review of clinical and experimental studies. Rotbart HA, Martino TA, Liu P, Petric M, Sole MJ, Human Enterovirus Infections Washington, DC: American Society for Microbiology Press, Rotbart HA, 1995 291 352
32. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U, Circulation 2006 114 1581 1590 10.1161/CIRCULATIONAHA.105.606509 17015795 (Pubitemid 44547428)
33. Supraventricular tachycardia in an infant associated with a rhinoviral infection. Spencer MJ, Cherry JD, Adams FH, Byatt PH, J Pediatr 1975 86 811 812
34. Epidemiology of viral infections of the heart. Grist NR, Reid D, Viral Infections of the Heart London: Hodder and Stoughton, Banatvala JE, 1993 23 31
35. Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. Jansen RR, Wieringa J, Koekkoek SM, Visser CE, Pajkrt D, Molenkamp R, de Jong MD, Schinkel J, J Clin Microbiol 2011 49 2631 2636 10.1128/JCM.02094-10 21543571
36. Advances in the understanding of myocarditis. Liu PP, Mason JW, Circulation 2001 104 1076 1082 10.1161/hc3401.095198 11524405 (Pubitemid 32803888)
37. Eosinophilic myocarditis temporally associated with conjugate meningococcal C and hepatitis B vaccines in children. Barton M, Finkelstein Y, Opavsky MA, Ito S, Ho T, Ford-Jones LE, Taylor G, Benson L, Gold R, Pediatr Infect Dis J 2008 27 831 835 10.1097/INF.0b013e31816ff7b2 18664932
38. Live attenuated malaria vaccine designed to protect through hepatic CD8§ssup§+§esup§ T cell immunity. Epstein JE, Tewari K, Lyke KE, Sim BK, Billingsley PF, Laurens MB, Gunasekera A, Chakravarty S, James ER, Sedegah M, Richman A, Velmurugan S, Reyes S, Li M, Tucker K, Ahumada A, Ruben AJ, Li T, Stafford R, Eappen AG, Tamminga C, Bennett JW, Ockenhouse CF, Murphy JR, Komisar J, Thomas N, Loyevsky M, Birkett A, Plowe CV, Loucq C, et al. Science 2011 334 475 480 10.1126/science.1211548 21903775
39. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, Holman LA, James ER, Billingsley PF, Gunasekera A, Richman A, Chakravarty S, Manoj A, Velmurugan S, Li M, Ruben AJ, Li T, Eappen AG, Stafford RE, Plummer SH, Hendel CS, Novik L, Costner PJ, Mendoza FH, Saunders JG, Nason MC, Richardson JH, Murphy J, Davidson SA, Richie TL, et al. Science 2013 341 1359 1365 10.1126/science.1241800 23929949
40. Ellenhorn's medical toxicology: diagnosis and treatment of human poisoning. Ellenhorn MJ, Schonwald S, Ordog G, Wasserberger J, Baltimore, MD: Lippincott Williams & Wilkins 2 1997